Target Price | $253.56 |
Price | $259.06 |
Deviation | 2.12% |
Number of Estimates | 16 |
16 Analysts have issued a price target IBM 2026 . The average IBM target price is $253.56. This is 2.12% lower than the current stock price. The highest price target is $300.00 15.80% , the lowest is $170.00 34.38% . | |
A rating was issued by 22 analysts: 11 Analysts recommend IBM to buy, 8 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the IBM stock has an average upside potential 2026 of 2.12% . Most analysts recommend the IBM stock at Purchase. |
16 Analysts have issued a sales forecast IBM 2025 . The average IBM sales estimate is $66.2b . This is 5.40% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $66.8b 6.27% , the lowest is $64.9b 3.34% .
This results in the following potential growth metrics:
2024 | $62.8b | 1.44% |
---|---|---|
2025 | $66.2b | 5.53% |
2026 | $69.1b | 4.37% |
2027 | $72.1b | 4.27% |
2028 | $74.1b | 2.78% |
2029 | $77.8b | 4.96% |
10 Analysts have issued an IBM EBITDA forecast 2025. The average IBM EBITDA estimate is $17.4b . This is 70.55% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $18.8b 84.19% , the lowest is $14.8b 44.90% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $14.4b | 47.19% |
---|---|---|
2025 | $17.4b | 20.83% |
2026 | $18.5b | 6.43% |
2027 | $19.2b | 3.77% |
2028 | $16.2b | 15.94% |
2029 | $17.4b | 7.40% |
2024 | 22.95% | 45.10% |
---|---|---|
2025 | 26.28% | 14.49% |
2026 | 26.80% | 1.98% |
2027 | 26.67% | 0.49% |
2028 | 21.81% | 18.22% |
2029 | 22.32% | 2.34% |
6 IBM Analysts have issued a net profit forecast 2025. The average IBM net profit estimate is $8.6b . This is 56.23% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $9.2b 67.24% , the lowest is $8.0b 46.18% .
This results in the following potential growth metrics and future Net Margins:
2024 | $6.0b | 19.71% |
---|---|---|
2025 | $8.6b | 41.99% |
2026 | $9.2b | 8.13% |
2027 | $9.7b | 5.18% |
2028 | $9.8b | 1.19% |
2029 | $11.0b | 12.18% |
2024 | 9.60% | 20.86% |
---|---|---|
2025 | 12.91% | 34.51% |
2026 | 13.38% | 3.64% |
2027 | 13.49% | 0.82% |
2028 | 13.29% | 1.48% |
2029 | 14.20% | 6.85% |
6 Analysts have issued a IBM forecast for earnings per share. The average IBM EPS is $9.20 . This is 58.89% higher than earnings per share in the financial year 2024. The highest EPS forecast is $9.85 70.12% , the lowest is $8.61 48.70% .
This results in the following potential growth metrics and future valuations:
2024 | $6.42 | 21.03% |
---|---|---|
2025 | $9.20 | 43.30% |
2026 | $9.95 | 8.15% |
2027 | $10.47 | 5.23% |
2028 | $10.59 | 1.15% |
2029 | $11.88 | 12.18% |
Current | 44.74 | 129.36% |
---|---|---|
2025 | 28.15 | 37.08% |
2026 | 26.04 | 7.50% |
2027 | 24.75 | 4.95% |
2028 | 24.46 | 1.17% |
2029 | 21.81 | 10.83% |
Based on analysts' sales estimates for 2025, the IBM stock is valued at an EV/Sales of 4.33 and an P/S ratio of 3.64 .
This results in the following potential growth metrics and future valuations:
Current | 4.56 | 43.40% |
---|---|---|
2025 | 4.33 | 5.10% |
2026 | 4.15 | 4.19% |
2027 | 3.98 | 4.10% |
2028 | 3.87 | 2.71% |
2029 | 3.69 | 4.73% |
Current | 3.83 | 51.52% |
---|---|---|
2025 | 3.64 | 5.12% |
2026 | 3.48 | 4.19% |
2027 | 3.34 | 4.10% |
2028 | 3.25 | 2.71% |
2029 | 3.10 | 4.73% |
Analyst | Rating | Action | Date |
---|---|---|---|
RBC Capital |
Outperform
➜
Outperform
|
Unchanged | May 15 2025 |
Wedbush |
Outperform
➜
Outperform
|
Unchanged | May 07 2025 |
Wedbush |
Outperform
➜
Outperform
|
Unchanged | Apr 24 2025 |
Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 24 2025 |
UBS |
Sell
➜
Sell
|
Unchanged | Apr 24 2025 |
RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Apr 14 2025 |
Jefferies |
Hold
➜
Hold
|
Unchanged | Mar 31 2025 |
Analyst Rating | Date |
---|---|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
May 15 2025 |
Unchanged
Wedbush:
Outperform
➜
Outperform
|
May 07 2025 |
Unchanged
Wedbush:
Outperform
➜
Outperform
|
Apr 24 2025 |
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Apr 24 2025 |
Unchanged
UBS:
Sell
➜
Sell
|
Apr 24 2025 |
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Apr 14 2025 |
Unchanged
Jefferies:
Hold
➜
Hold
|
Mar 31 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.